Virginia Commonwealth University.
Duke University.
Oncol Nurs Forum. 2022 Aug 18;49(5):445-453. doi: 10.1188/22.ONF.445-453.
Hematologic malignancies (HMs) are life-threatening cancers that frequently entail aggressive, long, inpatient treatment protocols. This can result in numerous concurrent symptoms and decreased quality of life for patients and can affect family caregivers (FCs). This study examined the impact of an HM diagnosis on patients and on their FCs.
SAMPLE & SETTING: A descriptive design was used to explore the experiences of 28 newly diagnosed patients and their FCs. All patients were receiving treatment on an inpatient acute oncology unit at a National Cancer Institute-designated cancer center.
METHODS & VARIABLES: Semistructured, separate interviews with patients and FCs were recorded and transcribed verbatim. Textual and content analyses were conducted to generate common themes.
Patients and FCs reported how diagnosis and treatment affected them physically, emotionally, logistically, and financially. They described the effects of their experiences with the health system and providers in areas such as diagnostic process, trust in the medical team, support needs, and hospitalization.
Understanding the parallel experiences of patients with HMs and their designated FCs allows researchers to develop targeted interventions and enables clinicians to provide personalized patient- and family-centered care.
血液系统恶性肿瘤(HMs)是危及生命的癌症,通常需要积极、长期的住院治疗方案。这可能导致患者出现许多并发症状和生活质量下降,并影响家庭照顾者(FCs)。本研究探讨了 HM 诊断对患者及其 FCs 的影响。
本研究采用描述性设计,探讨了 28 名新诊断的患者及其 FCs 的经历。所有患者均在国家癌症研究所指定癌症中心的急性肿瘤病房接受治疗。
对患者和 FCs 进行了半结构化的单独访谈,并逐字记录和转录。进行了文本和内容分析以生成共同的主题。
患者和 FCs 报告了诊断和治疗如何在身体、情感、后勤和财务方面影响他们。他们描述了他们在诊断过程、对医疗团队的信任、支持需求和住院等方面的医疗系统和提供者体验的影响。
了解 HM 患者及其指定 FCs 的平行经历,使研究人员能够开发有针对性的干预措施,并使临床医生能够提供个性化的以患者和家庭为中心的护理。